Geron

GERN · NASDAQ

$1.24+$0.04 (+3.33%)TodayMarket closed · Oct 20, 7:31 PM ET

Prev close $1.20

Latest news

Press releaseOct 13, 2:52 PM ETPRNewswire
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Press releaseOct 12, 12:14 PM ETBusiness Wire
Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN
Press releaseOct 12, 8:03 AM ETGlobe Newswire
Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia
NewsOct 8, 4:19 AM ET
Geron Q2 2026 Earnings Call: Complete Transcript
Press releaseSep 25, 10:35 PM ETPRNewswire
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Press releaseSep 25, 10:00 PM ETPRNewswire
Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN
Press releaseSep 14, 2:16 PM ETBusiness Wire
Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN
Press releaseSep 2, 3:58 PM ETPRNewswire
Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Press releaseSep 2, 1:36 PM ETPRNewswire
Kuehn Law Encourages Investors of Geron Corporation to Contact Law Firm
Press releaseAug 5, 7:00 AM ETGlobe Newswire
Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Press releaseJul 13, 8:00 AM ETGlobe Newswire
Geron Announces Appointment of Chinmaya Rath as Chief Business Officer
Press releaseMay 20, 9:50 AM ETPRNewswire
Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
Press releaseMay 12, 9:31 AM ETGlobe Newswire
First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026
NewsMay 6, 5:03 PM ET
Earnings Scheduled For May 6, 2026
NewsMay 6, 8:51 AM ET
Geron Reports Q1 2026 Results: Full Earnings Call Transcript
Press releaseMay 6, 7:00 AM ETGlobe Newswire
Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights
NewsApr 13, 8:02 AM ETAvi Kapoor
Fastenal, Replimune Group, Children's Place And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Press releaseApr 13, 8:00 AM ETGlobe Newswire
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary
Press releaseMar 26, 8:00 AM ETGlobe Newswire
Geron Announces Appointment of New Members to its Board of Directors
Press releaseMar 3, 9:00 AM ETPRNewswire
Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
NewsFeb 25, 12:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsFeb 25, 7:02 AM ET
Earnings Summary: Geron Q4
NewsFeb 25, 6:11 AM ET
Earnings Scheduled For February 25, 2026
NewsFeb 19, 8:43 AM ETAvi Kapoor
Top 2 Industrials Stocks That Are Ticking Portfolio Bombs
NewsFeb 18, 9:04 AM ETAvi Kapoor
Top 3 Health Care Stocks That May Collapse This Quarter
NewsDec 18, 1:05 PM ETFahad Saleem
Investor Says He 'Doubled' His Savings After Using ChatGPT in Stock Research – Shares Top 5 Stock Picks
NewsDec 11, 5:05 AM ETAvi Kapoor
Why Planet Labs Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket
Press releaseDec 4, 12:20 PM ETPRNewswire
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points
Press releaseNov 5, 7:00 AM ETBusiness Wire
Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Press releaseNov 4, 8:00 AM ETBusiness Wire
Geron Corporation to Present at Upcoming Investor Conferences
Press releaseNov 3, 9:05 AM ETBusiness Wire
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
Press releaseOct 23, 6:14 PM ETGlobe Newswire
GERON (GERN) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Press releaseOct 20, 5:32 PM ETBusiness Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press releaseAug 27, 4:05 PM ETBusiness Wire
Geron to Participate in the 2025 Wells Fargo Healthcare Conference
Press releaseAug 18, 4:01 PM ETBusiness Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press releaseAug 13, 7:52 PM ETGlobe Newswire
GERON (GERN) ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Press releaseAug 8, 4:01 PM ETBusiness Wire
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NewsAug 6, 8:08 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseAug 6, 7:01 AM ETBusiness Wire
Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights
Press releaseAug 6, 7:00 AM ETBusiness Wire
Geron Appoints Harout Semerjian as President and Chief Executive Officer
Press releaseJul 28, 8:00 AM ETBusiness Wire
Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025
Press releaseJul 18, 4:05 PM ETBusiness Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press releaseJun 18, 4:10 PM ETBusiness Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Press releaseMay 28, 8:30 AM ETBusiness Wire
Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program
NewsMay 7, 8:09 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsFeb 26, 2:57 PM ETAvi Kapoor
Dow Dips Over 100 Points; TJX Earnings Top Views

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN

Geron Corporation Announces Oral Presentations Highlighting Imetelstat at International Hematology Congresses in Europe and Asia

Geron Q2 2026 Earnings Call: Complete Transcript

Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN

Geron Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Geron Corporation - GERN

Did Geron Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Kuehn Law Encourages Investors of Geron Corporation to Contact Law Firm

Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Geron Announces Appointment of Chinmaya Rath as Chief Business Officer

Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets

First Real-World Evidence Study of RYTELO® (imetelstat) in Lower-risk Myelodysplastic Syndromes (LR-MDS) to be Presented at EHA 2026

Earnings Scheduled For May 6, 2026

Geron Reports Q1 2026 Results: Full Earnings Call Transcript

Geron Corporation Reports First Quarter 2026 Financial Results and Recent Business Highlights

Fastenal, Replimune Group, Children's Place And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary

Geron Announces Appointment of New Members to its Board of Directors

Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone

12 Health Care Stocks Moving In Wednesday's Intraday Session

Earnings Summary: Geron Q4

Earnings Scheduled For February 25, 2026

Top 2 Industrials Stocks That Are Ticking Portfolio Bombs

Top 3 Health Care Stocks That May Collapse This Quarter

Investor Says He 'Doubled' His Savings After Using ChatGPT in Stock Research – Shares Top 5 Stock Picks

Why Planet Labs Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket

Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points

Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights

Geron Corporation to Present at Upcoming Investor Conferences

Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies

GERON (GERN) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron to Participate in the 2025 Wells Fargo Healthcare Conference

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GERON (GERN) ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Geron Appoints Harout Semerjian as President and Chief Executive Officer

Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Dow Dips Over 100 Points; TJX Earnings Top Views